Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
41
pubmed:dateCreated
2008-10-6
pubmed:abstractText
The molecular basis for divalent cationic permeability in transient receptor potential melastatin subtype (TRPM) channels is not fully understood. Here we studied the roles of all eight acidic residues, glutamate or aspartate, and also the glutamine residue between pore helix and selectivity filter in the pore of TRPM2 channel. Mutants with alanine substitution in each of the acidic residues, except Glu-960 and Asp-987, formed functional channels. These channels exhibited similar Ca(2+) and Mg(2+) permeability to wild type channel, with the exception of the E1022A mutant, which displayed increased Mg(2+) permeability. More conservative E960Q, E960D, and D987N mutations also led to loss of function. The D987E mutant was functional and showed greater Ca(2+) permeability along with concentration-dependent inhibition of Na(+)-carrying currents by Ca(2+). Incorporation of negative charge in place of Gln-981 between the pore helix and selectivity filter by changing it to glutamate, which is present in the more Ca(2+)-permeable TRPM channels, substantially increased Ca(2+) permeability. Expression of concatemers linking wild type and E960D mutant subunits resulted in functional channels that exhibited reduced Ca(2+) permeability. These data taken together suggest that Glu-960, Gln-981, Asp-987, and Glu-1022 residues are engaged in determining divalent cationic permeation properties of the TRPM2 channel.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-10859346, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-10931826, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-11035011, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-11385575, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-11509717, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-11804595, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12093812, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12456670, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12471162, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12508053, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12529379, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12594222, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12761352, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12765697, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-12887921, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-14576148, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-14654832, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-15275834, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-15530641, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-15574510, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-15731110, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-15824111, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-15845551, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-16104849, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-16460288, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-16601673, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-16604090, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-16857972, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-17060318, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-17098283, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-17237345, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-17579562, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-17599911, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-17884814, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-17893195, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-18048770, http://linkedlifedata.com/resource/pubmed/commentcorrection/18687688-18073331
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
283
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
27426-32
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Identification of pore residues engaged in determining divalent cationic permeation in transient receptor potential melastatin subtype channel 2.
pubmed:affiliation
Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't